1. Academic Validation
  2. SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells

SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells

  • Cell Discov. 2021 Dec 14;7(1):119. doi: 10.1038/s41421-021-00357-z.
Jinliang Wang  # 1 Guan Yang  # 2 Xinxin Wang  # 1 Zhiyuan Wen 1 Lei Shuai 1 Jie Luo 1 Chong Wang 1 Ziruo Sun 1 Renqiang Liu 1 Jinying Ge 1 Xijun He 1 Ronghong Hua 1 Xijun Wang 1 Xiao Yang 2 Weiye Chen 1 Gongxun Zhong 1 Zhigao Bu 3
Affiliations

Affiliations

  • 1 State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang, China.
  • 2 State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
  • 3 State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang, China. [email protected].
  • # Contributed equally.
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses angiotensin-converting Enzyme 2 (ACE2) as a binding receptor to enter cells via clathrin-mediated endocytosis (CME). However, receptors involved in other steps of SARS-CoV-2 Infection remain largely unknown. Here, we found that metabotropic glutamate receptor subtype 2 (mGluR2) is an internalization factor for SARS-CoV-2. Our results show that mGluR2 directly interacts with the SARS-CoV-2 spike protein and that knockdown of mGluR2 decreases internalization of SARS-CoV-2 but not cell binding. Further, mGluR2 is uncovered to cooperate with ACE2 to facilitate SARS-CoV-2 internalization through CME and mGluR2 knockout in mice abolished SARS-CoV-2 Infection in the nasal turbinates and significantly reduced viral Infection in the lungs. Notably, mGluR2 is also important for SARS-CoV spike protein- and Middle East respiratory syndrome coronavirus spike protein-mediated internalization. Thus, our study identifies a novel internalization factor used by SARS-CoV-2 and opens a new door for Antiviral development against coronavirus Infection.

Figures
Products